PENTOXIFYLLINE IN ACUTE ISCHEMIC STROKE PATIENTS WITH BLOOD HYPERVISCOSITY

Authors

  • Al Rasyid Department of Neurology, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia,
  • Salim Harris Department of Neurology, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia,
  • Eny Nurhayat Department of Neurology, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia,
  • Joedo Prihartono Department of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta Pusat 10430, Indonesia.

DOI:

https://doi.org/10.22159/ijap.2018.v10s1.68

Keywords:

Blood hyperviscosity, Digital microcapillary, Ischemic stroke, Pentoxifylline

Abstract

Objective: This study evaluated the efficacy of pentoxifylline, a hemorrheologic agent, for treating acute ischemic stroke in patients with blood
hyperviscosity.
Methods: Patients were randomly allocated within 3 days of stroke onset to study or control treatment. All the patients received the standard acute
ischemic stroke treatment. The study treatment was intravenous pentoxifylline 1200 mg/day for 5 consecutive days and oral pentoxifylline 800 mg
in two divided doses for 23 days. Blood viscosity was evaluated on days 7 and 30. The outcomes were assessed by the National Institutes of Health
Stroke Scale (NIHSS), modified Rankin Scale, and Barthel index (BI) criteria.
Results: The median baseline viscosity was 6.89 poise in the study and 6.46 poise in the control groups and had decreased in all the patients on
days 7 and 30. The decrease in the study group on day 7 (1.13 poise) was greater than that in the control group (0.57 poise); the difference was not
significant. The NIHSS score improved by 32% in the study group (relative risk [RR]=1.00, 95% confidence interval [CI]: 0.421–3.556; p=1.00). At
1-month, 67% of the study group had a good functional outcome (RR=1.026, 95% CI: 0.656–1.605; p=0.909).
Conclusion: Pentoxifylline decreased blood viscosity and improved clinical outcome in this patient series.

Downloads

Download data is not yet available.

References

Ministry of Health. Basic Health Research. Agency of Health Research

and Development the Republic of Indonesia. Jakarta: Ministry of

Health Republic of Indonesia; 2013.

Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM,

et al. Change in stroke incidence, mortality, case-fatality, severity, and

risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford vascular

study). Lancet 2004;363:1925-33.

Fadhli H, Meisadona G, Kurniawan M, Mesiano T. Stroke Patient

Mortality in Cipto Mangunkusumo Hospital in 2014. Jakarta: Presented

at the Jakarta Neurology Workshop Exhibition and Symposium

(JAKNEWS); 2015.

Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A,

et al. An updated definition of stroke for the 21st century: A statement

for healthcare professionals from the American heart association/

American stroke association. Stroke 2013;44:2064-89.

Caplan LR, editor. Basic pathology, anatomy, and pathophysiology

of stroke. Caplan’s Stroke: A Clinical Approach. Philadelphia, PA:

Saunders Elsevier; 2009.

Ott E, Fazekas F, Tschinkel M, Bertha G, Lechner H. Rheological

aspects of cerebrovascular disease. Eur Neurol 1983;22 Suppl 1:35-7.

Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity

and risk of cardiovascular events: The Edinburgh artery study. Br J

Haematol 1997;96:168-73.

Thomas DJ. Whole blood viscosity and cerebral blood flow. Stroke

;14:1012-3.

Rasyid A, Misbach J, Purba JS, Timan IS, Sukrisman L, Mansyur M,

et al. The role of a novel digital microcapillary instrument in detecting

blood and plasma hyperviscosity. Acta Med Indones 2014;46:226-32.

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC,

Becker K, et al. 2018 guidelines for the early management of patients

with acute ischemic stroke: A guideline for healthcare professionals

from the American heart association/American stroke association.

Stroke 2018;49:e46-e110.

Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic

and pharmacokinetic properties, and its therapeutic efficacy. Drugs

;34:50-97.

Bowton DL, Stump DA, Prough DS, Toole JF, Lefkowitz DS, Coker L,

et al. Pentoxifylline increases cerebral blood flow in patients with

cerebrovascular disease. Stroke 1989;20:1662-6.

Vakili A, Mojarrad S, Akhavan MM, Rashidy-Pour A. Pentoxifylline

attenuates TNF-α protein levels and brain edema following temporary

focal cerebral ischemia in rats. Brain Res 2011;1377:119-25.

Rasyid A. The Effectiveness of Digital Microcapillers as a Measure

of the Value of Blood Viscosity to Predict the Prognosis of Acute

Ischemic Stroke. Dissertation. Jakarta: Faculty of Medicine Universitas

Indonesia; 2014.

Kuriakose C, Naseem SM, Tharakan NS, Sattanathan K, Sambath KR.

A prospective study of clinical profile of stroke in a tertiary care

hospital. Asian J Pharm Clin Res 2016;9:178-81.

Ahmed HH, Shousha WG, Mezayen HA, Emara IA, Hassan ME.

Clinical significance of procalcitonin and c-reactive protein in the

prediction of cardiovascular complications in patients with Type 2

diabetes mellitus. Asian J Pharm Clin Res 2017;10:297-306.

Kristiyowati AD, Andrajati R, Bahtiar A. Comparison of clopidogrel and

acetosal in the prevention of reccurent ischemic stroke at Dr. Moewardi

regional general hospital. Asian J Pharm Clin Res 2017;10:145-50.

Coull BM, Beamer N, de Garmo P, Sexton G, Nordt F, Knox R, et al.

Chronic blood hyperviscosity in subjects with acute stroke, transient

ischemic attack, and risk factors for stroke. Stroke 1991;22:162-8.

Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P,

et al. Inflammatory markers and poor outcome after stroke:

A prospective cohort study and systematic review of interleukin-6.

PLoS Med 2009;6:e1000145.

Hsu CY, Norris JW, Hogan EL, Bladin P, Dinsdale HB, Yatsu FM, et al.

Pentoxifylline in acute nonhemorrhagic stroke. A randomized, placebocontrolled

double-blind trial. Stroke 1988;19:716-22.

Published

20-12-2018

How to Cite

Rasyid, A., Harris, S., Nurhayat, E., & Prihartono, J. (2018). PENTOXIFYLLINE IN ACUTE ISCHEMIC STROKE PATIENTS WITH BLOOD HYPERVISCOSITY. International Journal of Applied Pharmaceutics, 10(1), 307–310. https://doi.org/10.22159/ijap.2018.v10s1.68

Issue

Section

Original Article(s)

Similar Articles

1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.